Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I N Bruce

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Lupus|October 13, 2005
Atherogenesis and autoimmune disease: the model of lupusI N Bruce
Rheumatology (Oxford, England)|October 20, 2005
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosusI N Bruce
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Psoriatic arthritis: recognition and managementI N Bruce, D D Gladman
Lupus|August 1, 2007
High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosusB J Parker, I N Bruce
British Journal of Rheumatology|April 1, 1997
A comparison of two nomenclature systems for primary systemic vasculitisI N Bruce, A L Bell
Arthritis Research|November 21, 2001
Genetic epidemiology: systemic lupus erythematosusY A Ahmad, I N Bruce
Rheumatology (Oxford, England)|June 26, 2007
The pharmacogenetics of methotrexateS L Hider, I N Bruce, W Thomson
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Hyperuricemia in psoriatic arthritis: prevalence and associated featuresI N Bruce, C T Schentag, D D Gladman
Rheumatic Diseases Clinics of North America|April 18, 2000
Premature atherosclerosis in systemic lupus erythematosusI N Bruce, D D Gladman, M B Urowitz
Lupus|March 21, 2014
Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLES Skeoch, S Haque, P Pemberton, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Lupus|October 13, 2005
Atherogenesis and autoimmune disease: the model of lupusI N Bruce
Rheumatology (Oxford, England)|October 20, 2005
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosusI N Bruce
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Psoriatic arthritis: recognition and managementI N Bruce, D D Gladman
Lupus|August 1, 2007
High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosusB J Parker, I N Bruce
British Journal of Rheumatology|April 1, 1997
A comparison of two nomenclature systems for primary systemic vasculitisI N Bruce, A L Bell
Arthritis Research|November 21, 2001
Genetic epidemiology: systemic lupus erythematosusY A Ahmad, I N Bruce
Rheumatology (Oxford, England)|June 26, 2007
The pharmacogenetics of methotrexateS L Hider, I N Bruce, W Thomson
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Hyperuricemia in psoriatic arthritis: prevalence and associated featuresI N Bruce, C T Schentag, D D Gladman
Rheumatic Diseases Clinics of North America|April 18, 2000
Premature atherosclerosis in systemic lupus erythematosusI N Bruce, D D Gladman, M B Urowitz
Lupus|March 21, 2014
Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLES Skeoch, S Haque, P Pemberton, et al.
Pageof 7